Skip to main content
. 2017 Jul 18;8:480. doi: 10.3389/fphar.2017.00480

FIGURE 4.

FIGURE 4

Relaxing responses to the PAR-2 agonist SLIGRL in isolated BA; effects of apixaban (APX). The vasodilatation to SLIGRL was assessed in intact arteries, in the absence (A) or in the presence (B) of NG-nitro-L-arginine (L-NNA, 0.1 mM), to block endogenous NO. BA was pre-constricted with 1 μM 5-hydroxytryptamine. Data are the mean ± SEM of 8–12 independent measurements. P < 0.01 versus Control. Two-way ANOVA.